Sandoz launches generic Intuniv

PRINCETON, N.J. — Sandoz has announced that it is introducing guanfacine hydrochloride extended-release tablets, a generic version of Intuniv, in 1-, 2-, 3- and 4-mg dosages. The guanfacine hydrochloride is a nonstimulant used to treat attention deficit hyperactivity disorder, either on its own or in combination with central nervous system stimulants.

 

“[ADHD] is one of the most common neurodevelopmental disorders of childhood, according to the Centers for Disease Control and Prevention,” said Peter Goldschmidt, President of Sandoz Inc. “Sandoz is pleased to add guanfacine hydrochloride extended release tablets to our portfolio of high-quality medicines for the central nervous system.”

 

Earlier this week, Teva launched its guanfacine hydrochloride tablets in the same strengths.